vs

Side-by-side financial comparison of DHT Holdings, Inc. (DHT) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

DHT Holdings, Inc. is the larger business by last-quarter revenue ($107.3M vs $83.1M, roughly 1.3× PROCEPT BioRobotics Corp). DHT Holdings, Inc. runs the higher net margin — 41.7% vs -38.1%, a 79.8% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -24.5%).

DHT Holdings, Inc. is an independent international crude oil tanker operator that owns and manages a fleet of very large crude carriers. It offers marine transportation services for crude oil across major global trade routes, serving clients including leading oil producers, refineries, and commodity trading enterprises worldwide.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

DHT vs PRCT — Head-to-Head

Bigger by revenue
DHT
DHT
1.3× larger
DHT
$107.3M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+44.7% gap
PRCT
20.2%
-24.5%
DHT
Higher net margin
DHT
DHT
79.8% more per $
DHT
41.7%
-38.1%
PRCT

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
DHT
DHT
PRCT
PRCT
Revenue
$107.3M
$83.1M
Net Profit
$44.8M
$-31.6M
Gross Margin
64.9%
Operating Margin
44.2%
-4.1%
Net Margin
41.7%
-38.1%
Revenue YoY
-24.5%
20.2%
Net Profit YoY
27.3%
-27.9%
EPS (diluted)
$0.28
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHT
DHT
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$76.4M
Q3 25
$107.3M
$83.3M
Q2 25
$79.2M
Q1 25
$69.2M
Q4 24
$68.2M
Q3 24
$142.1M
$58.4M
Q2 24
$53.4M
Net Profit
DHT
DHT
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$44.8M
$-21.4M
Q2 25
$-19.6M
Q1 25
$-24.7M
Q4 24
$-18.9M
Q3 24
$35.2M
$-21.0M
Q2 24
$-25.6M
Gross Margin
DHT
DHT
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
DHT
DHT
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
44.2%
-27.8%
Q2 25
-28.0%
Q1 25
-39.7%
Q4 24
-28.9%
Q3 24
29.7%
-38.4%
Q2 24
-50.3%
Net Margin
DHT
DHT
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
41.7%
-25.7%
Q2 25
-24.7%
Q1 25
-35.8%
Q4 24
-27.6%
Q3 24
24.8%
-35.9%
Q2 24
-48.0%
EPS (diluted)
DHT
DHT
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$0.28
$-0.38
Q2 25
$-0.35
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$0.22
$-0.40
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHT
DHT
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$81.3M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$1.1B
$347.7M
Total Assets
$1.4B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHT
DHT
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$81.3M
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$73.8M
$196.8M
Q2 24
$214.1M
Total Debt
DHT
DHT
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
DHT
DHT
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$1.1B
$380.3M
Q2 25
$385.8M
Q1 25
$389.2M
Q4 24
$402.2M
Q3 24
$1.0B
$241.2M
Q2 24
$251.8M
Total Assets
DHT
DHT
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$508.1M
Q3 25
$1.4B
$511.5M
Q2 25
$513.1M
Q1 25
$519.4M
Q4 24
$534.0M
Q3 24
$1.5B
$374.1M
Q2 24
$374.4M
Debt / Equity
DHT
DHT
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHT
DHT
PRCT
PRCT
Operating Cash FlowLast quarter
$60.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.36×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHT
DHT
PRCT
PRCT
Q1 26
Q4 25
$-10.3M
Q3 25
$60.9M
$-6.6M
Q2 25
$-15.0M
Q1 25
$-17.0M
Q4 24
$-32.4M
Q3 24
$80.1M
$-18.8M
Q2 24
$-15.7M
Free Cash Flow
DHT
DHT
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
DHT
DHT
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
DHT
DHT
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
DHT
DHT
PRCT
PRCT
Q1 26
Q4 25
Q3 25
1.36×
Q2 25
Q1 25
Q4 24
Q3 24
2.28×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DHT
DHT

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons